Stockreport

Oragenics announces partnership with Receptor.AI [Seeking Alpha]

Oragenics Inc.  (OGEN) 
NASDAQ:AMEX Investor Relations: ir.oragenics.com
PDF The collaboration aims to expand Oragenics' pharmaceutical pipeline by using advanced AI to identify optimal receptor binding profiles for newly acquired compounds. T [Read more]